Ms. Aalto, Aursos President and CEO, joined Aursos in 2012 after serving as President of Accord BIosciences for three years. Prior to Accord, Ms. Aalto was the Coulter Translational Research Director at UM and an Entrepreneur in Residence with Arboretum Ventures. She has significant orthopedics industry experience including synthetic bone graft development and securing multiple FDA product clearances from previous roles with Stryker and Inion.

Dr. Shebuski has over 25 years' experience in the pharmaceutical industry and served as the Director of Cardiovascular Therapeutics at Pharmacia & Upjohn in Kalamazoo, MI from 1990-1998. He established a Cardiovascular Research Consulting Firm in 1998 and continues to serve small, mid and large pharma in many aspects of drug discovery and development.